15-deoxyprostaglandin-j2 has been researched along with Carcinoma--Small-Cell* in 1 studies
1 other study(ies) available for 15-deoxyprostaglandin-j2 and Carcinoma--Small-Cell
Article | Year |
---|---|
Peroxisome proliferator-activated receptor-gamma activated by ligands can inhibit human lung cancer cell growth through induction of apoptosis.
To study the expression of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) in lung cancer cells, and to testify if the PPAR-gamma agonists can inhibit human lung cancer cell growth through induction of apoptosis, PPAR-gamma was detected in two lung cancer cell lines by RT-PCR and immunohistochemistry, the inhibition of human lung cancer cell growth was investigated by MTT and cell counts, and the apoptosis was assessed by TUNEL. The results showed that: (1) PPAR-gamma expressed on two lung cancer cell lines; (2) PPAR-gamma activated by ligands could inhibit human lung cancer cell growth remarkably; (3) PPAR-gamma agonists could induce apoptosis to inhibit lung cancer cell growth. It was concluded that PPAR-gamma expressed in lung cancer cell can be activated by ligands and can inhibit lung cancer cell growth through induction of apoptosis. Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Division; Gene Expression Regulation, Neoplastic; Humans; Ligands; Lung Neoplasms; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Tumor Cells, Cultured | 2003 |